Lee Cooper
Company: Bayer
Job title: Senior Director - Venture Investments
Seminars:
What Can Emerging Induced Proximity Modalities Learn from TPD’s Journey to Accelerate Their Development 9:05 am
Targeted protein degradation (TPD) has been the most advanced induced proximity modality for the last decade. As the first and most advanced modality, TPD’s journey from an academic idea to proof-of-concept to the clinic has many valuable learnings for other emerging modalities in the induced proximity field. This workshop will seek to leverage the experience…Read more
day: Workshop A